A smart ATP-responsive chemotherapy drug-free delivery system using a DNA nanostructure for synergistic treatment of breast cancer in vitro and in vivo

References

• Tian F, Dahmani FZ, Qiao J, et al. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer. Acta Biomater. 2018;75:398–412.
   PubMed Web of Science ®Google Scholar
• Soe ZC, Thapa RK, Ou W, et al. Folate receptor-mediated celastrol and irinotecan combination delivery using liposomes for effective chemotherapy. Colloids Surf B Biointerfaces. 2018;170:718–728.
   PubMed Web of Science ®Google Scholar
• Zhang J, Du Z, Pan S, et al. Overcoming multidrug resistance by codelivery of MDR1-targeting siRNA and doxorubicin using EphA10-mediated pH-sensitive lipoplexes: in vitro and in vivo evaluation. ACS Appl Mater Interfaces. 2018;10:21590–21600.
   PubMed Web of Science ®Google Scholar
• Liu S, Ono RJ, Yang C, et al. Dual pH-responsive shell-cleavable polycarbonate micellar nanoparticles for in vivo anticancer drug delivery. ACS Appl Mater Interfaces. 2018;10:19355–19364.
   PubMed Web of Science ®Google Scholar
• Yung BC, Li J, Zhang M, et al. Lipid nanoparticles composed of quaternary amine-tertiary amine cationic lipid combination (QTsome) for therapeutic delivery of AntimiR-21 for lung cancer. Mol Pharmaceutics. 2016;13:653–662.
   PubMed Web of Science ®Google Scholar
• Jahanafrooz Z, Motamed N, Bakhshandeh B. Effects of miR-21 downregulation and silibinin treatment in breast cancer cell lines. Cytotechnology. 2017;69:667–680.
   PubMed Web of Science ®Google Scholar
• Ma X, Conklin DJ, Li F, et al. The oncogenic microRNA miR-21 promotes regulated necrosis in mice. Nat Commun. 2015;6. Article number: 7151.
   Web of Science ®Google Scholar
• Yan LX, Liu YH, Xiang JW, et al. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer. Int J Oncol. 2016;48:471–484.
   PubMed Web of Science ®Google Scholar
• Devulapally R, Sekar NM, Sekar TV, et al. Polymer nanoparticles mediated codelivery of AntimiR-10b and AntimiR-21 for achieving triple negative breast cancer therapy. ACS Nano. 2015;9:2290–2302.
   PubMed Web of Science ®Google Scholar
• Devulapally R, Sekar TV, Paulmurugan R. Formulation of anti-miR-21 and 4-hydroxytamoxifen co-loaded biodegradable polymer nanoparticles and their antiproliferative effect on breast cancer cells. Mol Pharmaceutics. 2015;12:2080–2092.
   PubMed Web of Science ®Google Scholar
• Jung HK, Kim S, Park RW, et al. Bladder tumor-targeted delivery of pro-apoptotic peptide for cancer therapy. J Control Release. 2016;235:259–267.
   PubMed Web of Science ®Google Scholar
• Wang F, Sun W, Li L, et al. Charge-reversible multifunctional HPMA copolymers for mitochondrial targeting. ACS Appl Mater Interfaces. 2017;9:27563–27574.
   PubMed Web of Science ®Google Scholar
• Foillard S, Sancey L, Coll JL, et al. Targeted delivery of activatable fluorescent pro-apoptotic peptide into live cells. Org Biomol Chem. 2009;7:221–224.
   PubMed Web of Science ®Google Scholar
• Sun J, Jiang L, Lin Y, et al. Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides. Int J Nanomedicine. 2017;12:1517–1537.
   PubMed Web of Science ®Google Scholar
• Kim CH, Tworoger SS, Stampfer MJ, et al. Stability and reproducibility of proteomic profiles measured with an aptamer-based platform. Sci Rep. 2018;8:8382.
   PubMed Web of Science ®Google Scholar
• Patel KA, Chaudhary RK, Roy I. RNA aptamers rescue mitochondrial dysfunction in a yeast model of Huntington’s disease. Mol Ther Nucleic Acids. 2018;12:45–56.
   PubMedGoogle Scholar
• Hu Y, Li X, An Y, et al. Selection of a novel CD19 aptamer for targeted delivery of doxorubicin to lymphoma cells. Oncotarget. 2018;9:26605–26615.
   PubMedGoogle Scholar
• Abnous K, Danesh NM, Ramezani M, et al. A novel colorimetric aptasensor for ultrasensitive detection of cocaine based on the formation of three-way junction pockets on the surfaces of gold nanoparticles. Anal Chim Acta. 2018;1020:110–115.
   PubMed Web of Science ®Google Scholar
• Dong H, Han L, Wang J, et al. In vivo inhibition of circulating tumor cells by two apoptosis-promoting circular aptamers with enhanced specificity. Journal of Controlled Release. 2018;280:99–112.
   PubMed Web of Science ®Google Scholar
• Wu Q, Wang Y, Wang H, et al. DNA aptamers from whole-cell SELEX as new diagnostic agents against glioblastoma multiforme cells. Analyst. 2018;143:2267–2275.
   PubMed Web of Science ®Google Scholar
• Taghdisi SM, Danesh NM, Ramezani M, et al. A novel AS1411 aptamer-based three-way junction pocket DNA nanostructure loaded with doxorubicin for targeting cancer cells in vitro and in vivo. Mol Pharm. 2018;15:1972–1978.
   PubMedGoogle Scholar
• Guo X, Zhuang Q, Ji T, et al. Multi-functionalized chitosan nanoparticles for enhanced chemotherapy in lung cancer. Carbohydr Polym. 2018;195:311–320.
   PubMed Web of Science ®Google Scholar
• Niu W, Teng IT, Chen X, et al. Aptamer-mediated selective delivery of a cytotoxic cationic NHC-Au(i) complex to cancer cells. Dalton Trans. 2018;47:120–126.
   Web of Science ®Google Scholar
• Yang S, Ren Z, Chen M, et al. Nucleolin-targeting AS1411-aptamer-modified graft polymeric micelle with dual pH/redox sensitivity designed to enhance tumor therapy through the codelivery of doxorubicin/TLR4 siRNA and suppression of invasion. Mol Pharm. 2018;15:314–325.
   PubMedGoogle Scholar
• Li X, Yu Y, Ji Q, et al. Targeted delivery of anticancer drugs by aptamer AS1411 mediated Pluronic F127/cyclodextrin-linked polymer composite micelles. Nanomedicine. 2015;11:175–184.
   PubMed Web of Science ®Google Scholar
• Kotula JW, Pratico ED, Ming X, et al. Aptamer-mediated delivery of splice-switching oligonucleotides to the nuclei of cancer cells. Nucleic Acid Ther. 2012;22:187–195.
   PubMed Web of Science ®Google Scholar
• Dam DHM, Lee RC, Odom TW. Improved in vitro efficacy of gold nanoconstructs by increased loading of G-quadruplex aptamer. Nano Lett. 2014;14:2843–2848.
   PubMed Web of Science ®Google Scholar
• Akhter MH, Rizwanullah M, Ahmad J, et al. Nanocarriers in advanced drug targeting: setting novel paradigm in cancer therapeutics. Artif Cells Nanomed Biotechnol. 2018;46:873–884.
   PubMed Web of Science ®Google Scholar
• Öztürk-Atar K, Eroğlu H, Çalış S. Novel advances in targeted drug delivery. J Drug Target. 2018;26:633–642.
   PubMed Web of Science ®Google Scholar
• Afsharzadeh M, Hashemi M, Mokhtarzadeh A, et al. Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment. Artif Cells Nanomed Biotechnol. 2018;46:1095–1110.
   PubMed Web of Science ®Google Scholar
• Aftab S, Shah A, Nadhman A, et al. Nanomedicine: an effective tool in cancer therapy. Int J Pharm. 2018;540:132–149.
   PubMed Web of Science ®Google Scholar
• Alves ID, Carré M, Montero M-P, et al. A proapoptotic peptide conjugated to penetratin selectively inhibits tumor cell growth. Biochim Biophys Acta. 2014;1838:2087–2098.
   PubMed Web of Science ®Google Scholar
• Fu B, Long W, Zhang Y, et al. Enhanced antitumor effects of the BRBP1 compound peptide BRBP1-TAT-KLA on human brain metastatic breast cancer. Sci Rep. 2015;5:8029.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang Y, Chen J, et al. Inhibition of cell proliferation through an ATP-responsive co-delivery system of doxorubicin and Bcl-2 siRNA. Int J Nanomedicine. 2017;12:4721–4732.
   PubMed Web of Science ®Google Scholar
• Qian Y, Wang X, Liu Y, et al. Extracellular ATP is internalized by macropinocytosis and induces intracellular ATP increase and drug resistance in cancer cells. Cancer Lett. 2014;351:242–251.
   PubMed Web of Science ®Google Scholar
• Schwiebert EM, Zsembery A. Extracellular ATP as a signaling molecule for epithelial cells [Review]. Biochim Biophys Acta. 2003;1615:7–32.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Tao C, Yin J, et al. Enhancing the response rate of strand displacement-based electrochemical aptamer sensors using bivalent binding aptamer-cDNA probes. Biosens Bioelectron. 2018;103:39–44.
   PubMed Web of Science ®Google Scholar